Close

Jump to:

  • Navigation
  • Content
  • Footer
Morph hero image

Morph

Follow

A pioneering health tech platform that aims to provide the most efficient path to optimal health

102%
 - 
Funded 1 Apr 2022
£250,002 target
£256,183 from 155 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website www.morph.fit
Sectors Healthcare Mixed Digital/Non-Digital Mixed B2B/B2C
Company number 12106103
Incorporation date 16 Jul 2019
More
Less

Investment summary

Type Equity
Valuation (pre-money) £3.4M
Equity offered 7.01%
Share price £3.4
Tax relief

SEIS

More
Less

Business highlights

  • Capitilising on a gap in an expanding market worth over $4.75trn
  • Core team has over 30 years experience in exercise science
  • Built an entirely new framework for digital health assessment
  • Have already secured corporate contracts across multiple sectors
More
Less

Key features

  • Secondary Market
  • Seedrs nominee min. £10.20 +
  • Idea
  • Key Information
  • Team
  • Updates
  • Investors 155
  • Discussion
  • Documents

Idea

Introduction

The problem we are addressing is big, global and growing. We have witnessed thousands of people struggle to achieve their health goals and more recently Covid's impact on public health awareness and increasing demand for continuous health assessment.

Morph is your ever-expanding ecosystem for successful healthy living, a platform that aims to provide users with the most efficient path to optimal health.

Our Fitness Passport accrues physiological and biometric data from user and trainer input to provide progress metrics and actionable recommendations that are completely personalised to every individual, developing a realistic roadmap of their journey ahead. We have created an entirely new framework for digital movement assessment, making our programs even more individualised, leading to maximum results in minimal time. 

Morph provides the feedback, support and community you need for optimal adherence and progress.

Substantial accomplishments to date

Morph has compiled an internationally acclaimed team of advisers in each area:

• Founders have more than 30 years combined experience in the health industry and compiled over 10,000 hours of analysing client movements.

• Rob, a Sport Scientist, has worked with celebrities & high net worth individuals in both the UK and US. Rob currently has a fitness business focused on delivering fast training sessions for the busy Londoner. He also works as a fitness consultant for several companies including online publication Buzz.ie.

• Jodi has worked as an international fitness consultant on every continent. He has worked with professional athletes, bodybuilders & celebrities.

• The tech development team has created and developed complex AI solutions for many global companies with a strong background in blockchain algorithm development.

• In partnership with leading Azure CSP, Extrinsica Global, who will be hosting, securing and scaling our ever-evolving IP.

• Advisory board includes internationally acclaimed Medical practitioners Dr. Cenk Oguz and Sports Science Doctor Dr. Ralph Rogers. Also renowned Osteopath and lecturer Emanuel Calabrese and experienced Chief Executive Sarah Fisher-Sabin.

• Global health affiliates - PNOE, NASM, Premier Training and HyperIce

• Corporate contracts across different sectors.

• Built and tested two beta versions of Android and iOS apps accepted in the app stores

Monetisation strategy

Morph plans to earn revenue as a B2C & B2B service, offering subscription options, individual sessions and packages as well as packages specifically marketed to the corporate wellness sector.

The price range is between £35 - £55 per session and £85 monthly for a virtual coaching subscription.

We have seen a direct correlation between the level of member usage and member retention. In February 2020 before the pandemic, we experienced a 0.64% churn rate in over 2500 sessions, compared to the industry standard of up to 50% member churn rate.

We are launching in a prime market:

- Globally, the wellness economy represents 5.1% of total GDP. Roughly 1 in every 20 dollars spent by consumers worldwide is on wellness.
- Global wellness economy is expected to be worth $7trn by 2025.
- Corporate wellness market is expected to rise to $100bn by 2030.
- 75% of large employers implement corporate wellness programs.

We have already secured corporate wellness Letters of Intent across multiple industries which will be commencing in Q2 2022.

Use of proceeds

Our goal for the next year is to launch Morph and grow to a user base of 10,000 individuals within the first year. We aim to achieve this by implementing our go-to-market strategy.

Funds from this campaign will be invested in the following:

35% in tech development

30% in marketing

25% in team acquisition and salaries

10% in equipment

Key Information

SEIS Tax Relief

The company has its full £150,000 SEIS allowance for this round. The first £180,000 into the campaign from offline investors is not taking up SEIS. Therefore those investing until the round reaches £330,000 will be eligible for SEIS, and funds raised after this amount will be EIS.

Material Debt

The company has an outstanding loan of £20,000 technology development credit from a company at no interest. The loan is to be repaid by 2025. None of the funds raised in this round will be used to repay this loan.

Director Disclosure

The Founder, Robert, is also a founder of Ultimate Bodytec a local health and wellbeing facility with a network of existing clients. Post raise, Robert will step down as director in Ultimate Bodytec.

Open an account to get access to the team members of Morph

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This webpage has been approved as a financial promotion by Seedrs Limited ("Seedrs"), which is authorised and regulated by the Financial Conduct Authority. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. The summary information provided about investment opportunities on this webpage is intended solely to demonstrate the types of investments available on the Seedrs platform, and any investment decision should be made on the basis of the full campaign. Full campaigns are available to investors who have become authorised to invest on the Seedrs platform. All investment activities take place within the United Kingdom, and any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing.

Seedrs does not make investment recommendations to you. No communications from Seedrs, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Seedrs does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Seedrs, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £3,400,000

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

Pitch type

There are 5 types of investment pitch available on Seedrs.

  • Equity
  • Convertible
  • Fund
  • Cohort
  • Secondary

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Seedrs nominee

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Seedrs nominee.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Seedrs Nominee). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Warning

You are following a link outside of www.seedrs.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel